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Lewis Dahl and the genetics of salt-induced hypertension
In the 1960s, Lewis Dahl bred two strains of rats that differed in their suscepti-
bility to developing salt-induced hypertension. These animal models proved that 
hypertension induced by a high-salt diet is influenced by genetic background.
The notion that hypertension is caused 
by a high-salt diet is more than a hundred 
years old, but much of its history is 
punctuated by controversy. The earliest 
study that reported a positive correlation 
between salt intake and blood pressure in 
humans was published in 1904 and was 
refuted just three years later (1). Although 
this ambiguity was echoed by numerous 
reports over the next 40 years, the 
validity of the link was reinforced in the 
1940s when a physician named Wallace 
Kempner successfully treated hypertensive 
patients with a low-salt diet (2). Other 
researchers then launched population 
studies that measured blood pressure in 
response to the level of salt ingestion.
Genetic susceptibility
The population study that captured the 
most attention was performed by Lewis 
Dahl, a physician at the Brookhaven 
National Laboratory (Upton, NY). 
Dahl’s unique contribution was to 
compare hypertension across various 
populations, as salt intake levels vary 
widely among geographically distinct 
groups (3). He found that hypertension 
was common in societies with higher-
than-average salt intakes. In contrast, 
hypertension was rarely seen in 
populations that consumed low-salt 
diets. Dahl also observed that every 
population included individuals who 
consistently consumed excess salt but 
did not develop hypertension. He 
therefore argued that the development 
of hypertension depends on both 
environmental factors (e.g., salt) and 
the individual’s genetic background.
Results from animal studies backed 
up his hypothesis. Over a period of 15 
years, Dahl observed that only three-
fourths of rats chronically fed with a 
high-salt diet developed varying degrees 
of hypertension (4). Salt-resistant 
animals, however, might simply have 
been statistical outliers within a 
genetically homogeneous group. Dahl 
reasoned that, if salt sensitivity was a 
genetic trait, it would be possible to 
develop separate strains of salt-sensitive 
and salt-resistant rats.
Selecting for sensitivity
Dahl began a breeding program in 
which rats were fed highly salted food 
to generate easily discernable differences 
in blood pressure. Rats either remained 
healthy or developed high blood 
pressure within four weeks. Dahl then 
crossed animals within each of the two 
groups, and after only 3 generations, 
the salt-sensitive (S) and salt-resistant 
(R) rat lines were clearly separated. 
The blood pressure of R rats remained 
the same when they were switched 
from a control diet to a high-salt diet. 
But in S rats, this switch induced a 
deadly increase in blood pressure. S rats 
that were maintained on a control diet 
did not develop hypertension, proving 
that the right diet can keep hypertension 
at bay even in susceptible individuals. 
These seminal results were published 
in the Journal of Experimental Medicine 
in 1962 (5).
The new model delivers
Dahl’s work over the next 10 years 
resulted in several improvements in diet-
based control of hypertension in humans. 
He found that salt-induced blood pressure 
in S rats could be reduced by increasing 
dietary potassium levels (6)—now a 
successful treatment option for many 
hypertensive patients in conjunction with 
a low-salt diet. He also demonstrated the 
dangers of high salt content in processed 
baby food when he showed that this food 
induced fatal hypertension in S rats (7).
Salt reduction regimens have been 
controversial within the hypertension 
field, as skeptics questioned whether 
these diets will be universally benefi-
cial. Dahl’s work, which emphasizes 
the interaction between gene and en-
vironment in raising blood pressure, 
gives reduction therapy a strong en-
dorsement. “We can’t change people’s 
genes,” says epidemiologist Paul 
  Elliott. “But we can certainly change 
their environment to lower their risk 
[for hypertension].”
Dahl also left another legacy: Dahl 
rats are still used in the search for 
hypertension-responsive genes and 
genetic markers of salt sensitivity. 
Linkage analyses and mapping studies 
have so far yielded 16 regions in the S 
rat genome that may contain genes that 
regulate hypertension (8). The single 
gene identified so far encodes 11 β-
hydroxylase, an enzyme required for 
the synthesis of a steroid that stimulates 
salt retention. It’s their allele of this gene 
that gives S rats their hypertension (9).
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